Physician profile
Anne Marie Antoine Irani
NPI 1235233669
$265,141.91
in general payments reported to CMS, 2019-2025
8 companies · $256K in 2025
The $256K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,657 · 2023: $889 · 2024: $190 · 2025: $256K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $255K · Food and Beverage: $2,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $255,286.00 |
| Food and Beverage | $2,198.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $255,703.16 | 2025 | Palforzia, Oralair |
| Glaxosmithkline, LLC. | $7,633.17 | 2019-2025 | Nucala |
| Blueprint Medicines Corporation | $718.90 | 2023-2025 | Ayvakit |
| Regeneron Healthcare Solutions, INC. | $360.76 | 2019-2025 | Dupixent |
| Genzyme Corporation | $259.31 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $232.49 | 2023-2025 | |
| Novo Nordisk INC | $124.00 | 2025 | Wegovy |
| Genentech USA, INC. | $110.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Marie Irani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.